Melanoma Prognostic Instrument vs Dermatology & Venereology Usage & Stats
The Prognostic Instrument for Melanoma (version 2.0) is a population-based tool that is based on a large amount of clinical and histopathological data from the Swedish quality registry for cutaneous melanoma (SweMR). In this updated version of the instrument, data from more than 70,000 patients with primary malignant melanoma between 1990 and 2021 have been included. Through a combination of several independent risk factors, melanoma-specific survival has been analysed for a variety of risk groups. The instrument calculates survival 1 to 10 years after diagnosis and provides an analysis at group level but can never provide an exact individual prognosis. The results are presented with 95% confidence intervals.
The prognostic instrument has been designed for use by physicians in relation to patients with primary malignant melanoma.
The analyses that form the basis of the instrument are performed on separate models for thin melanomas (≤ 1mm) and thicker melanomas (> 1mm) due to the fact that sentinel lymph node biopsy (SLNB) is generally not recommended for thin melanomas in Sweden. When choosing a thickness of 1 mm or less in the instrument, "Sentinel lymph node status" will not be included as a parameter.
- Apple App Store
- Free
- Medical
Store Rank
- -
Global Journal of Dermatology & Venereology is a peer-reviewed journal that publishes original research articles, review articles, and clinical studies in all areas of dermatology and sexually transmitted infections. It publishes high quality manuscripts covering the entire scope of dermatology, from molecular studies to clinical investigations and sexually transmitted infections (STI) with emphasis on local characteristics. The journal aims to advance understanding, management and treatment of skin disease and STI to improve patient outcomes.
The article categories within the journal include (but are not limited to) the following fields:
Skin Physiology and Biochemistry
Dermatological surgery
Pediatrics dermatology
Photobiology; and therapeutics
Allergy and Skin Toxicology
Immunology
Gonorrhea
Syphilis
Dermatological cancer
Human Immunodeficiency Virus
Hepatitis B virus
Herpes simplex virus (1, 2)
Laser therapy
==================================
The magazine offers a yearly (1.79€/1.99$) auto-renewable subscription
- Payment will be charged to iTunes Account at confirmation of purchase
- Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period
- Subscriptions may be managed by the user and auto-renewal may be turned off by going to the user's Account Settings after purchase
==================================
This magazine is proudly powered by PressPad.
Privacy Policy: https://presspadapp.com/terms-apps/
Terms of Use https://www.presspadapp.com/terms/
- Apple App Store
- Free
- Health & Fitness
Store Rank
- -
Melanoma Prognostic Instrument VS. 
Dermatology & VenereologyJanuary 15, 2025